NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Cash and Short Term Investments (Quarterly): 144.18M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 144.18M |
| September 30, 2023 | 166.04M |
| June 30, 2023 | 193.54M |
| March 31, 2023 | 231.00M |
| December 31, 2022 | 271.49M |
| September 30, 2022 | 300.15M |
| June 30, 2022 | 297.81M |
| March 31, 2022 | 329.83M |
| December 31, 2021 | 366.25M |
| September 30, 2021 | 383.43M |
| June 30, 2021 | 390.55M |
| March 31, 2021 | 412.66M |
| Date | Value |
|---|---|
| December 31, 2020 | 295.16M |
| September 30, 2020 | 287.95M |
| June 30, 2020 | 312.10M |
| March 31, 2020 | 328.47M |
| December 31, 2019 | 344.51M |
| September 30, 2019 | 356.57M |
| June 30, 2019 | 362.19M |
| March 31, 2019 | 193.44M |
| December 31, 2018 | 206.63M |
| June 30, 2018 | 189.23M |
| December 31, 2017 | 173.68M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
144.18M
Minimum
Dec 2023
412.66M
Maximum
Mar 2021
303.89M
Average
312.10M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Catalent Inc | 162.00M |
| AIM ImmunoTech Inc | 10.94M |
| Perspective Therapeutics Inc | 180.65M |
| Protalix BioTherapeutics Inc | 48.49M |
| Armata Pharmaceuticals Inc | 37.86M |